Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancer

Purpose: Pemetrexed is the only FDA approved treatment for mesothelioma and is a second line agent for treatment of non-small cell lung carcinoma (NSCLC). Pemetrexed is inhibited by folate and its analogs, which are components of many culture media, making it challenging to study pemetrexed in vitro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer biology & therapy 2013-01, Vol.14 (1), p.0-1
Hauptverfasser: Stacey L. Brower, Matthew J. Schuchert, Rodney J. Landreneau, Sarah L. Suchy, Dakun Wang, Paul R. Ervin, Jr
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!